Kyorin Pharmaceutical Co Ltd 4569
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- JPY 1,810.00
- Day Range
- JPY 1,801.00–1,828.00
- 52-Week Range
- JPY 1,700.00–1,880.00
- Bid/Ask
- JPY 1,821.00 / JPY 1,829.00
- Market Cap
- JPY 104.75 Bil
- Volume/Avg
- 84,900 / 70,412
Key Statistics
- Price/Earnings (Normalized)
- 27.05
- Price/Sales
- 0.87
- Dividend Yield (Trailing)
- 2.84%
- Dividend Yield (Forward)
- 3.50%
- Total Yield
- 2.84%
Company Profile
Kyorin Pharmaceutical Co Ltd is engaged in manufacturing and sale of pharmaceutical products. The company manages its business in two reportable segments namely Pharmaceutical Business and the Consumer Healthcare (Skincare) Business. The Pharmaceutical business focuses on producing and selling ethical drugs, generic drugs and over-the-counter drugs. The Consumer Healthcare (Skincare) Business mainly sells and purchases skincare products. The company's products include Kipres, for treating bronchial asthma and allergic rhinitis; Mucodyne, a mucoregulant; Pentasa, for treating ulcerative colitis and Crohn's disease; and Uritos, for treating overactive bladder. Majority of the company's revenue comes from domestic sales.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,464
- Website
- https://www.kyorin-pharm.co.jp
Comparables
Valuation
|
Metric
|
4569
|
008930
|
DHG
|
|---|---|---|---|
Price/Earnings (Normalized) | 27.05 | 22.11 | 17.70 |
Price/Book Value | 0.83 | 2.89 | 3.04 |
Price/Sales | 0.87 | 1.83 | 2.95 |
Price/Cash Flow | 11.30 | 37.26 | 15.99 |
Price/Earnings
4569
008930
DHG
Financial Strength
|
Metric
|
4569
|
008930
|
DHG
|
|---|---|---|---|
Quick Ratio | 1.33 | 0.36 | 2.52 |
Current Ratio | 2.53 | 0.69 | 3.90 |
Interest Coverage | 94.05 | 13.78 | 33.41 |
Quick Ratio
4569
008930
DHG
Profitability
|
Metric
|
4569
|
008930
|
DHG
|
|---|---|---|---|
Return on Assets (Normalized) | 3.16% | 10.01% | 15.23% |
Return on Equity (Normalized) | 4.40% | 15.05% | 19.03% |
Return on Invested Capital (Normalized) | 3.57% | 12.80% | 14.15% |
Return on Assets
4569
008930
DHG
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Mppsgyshd | Frrv | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Gslzgtbrhr | Njxnk | $70.8 Bil | |
HLN
| Haleon PLC ADR | Gptvwtd | Vrgx | $38.2 Bil | |
VTRS
| Viatris Inc | Kwzcjhw | Tvvz | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Sswqxpk | Pglrn | $12.5 Bil | |
CTLT
| Catalent Inc | Hgmzdjrr | Rjqzjx | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Nvtxwppj | Sxlgm | $4.3 Bil | |
CURLF
| Curaleaf Holdings Inc | Jqdmnkqj | Mql | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Mqydkmgtj | Rwxxy | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Nnptkpljy | Kkpn | $2.9 Bil |